Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
593 studies found for:    lung neoplasms AND (woman OR women OR female)
Show Display Options
Rank Status Study
1 Recruiting Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR
Condition: Stage IV Lung Cancer
Interventions: Drug: Gefitinib;   Drug: Fulvestrant;   Drug: Erlotinib
2 Completed Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China
Condition: Lung Neoplasms
Intervention:
3 Completed Computed Tomography for Early Detection of Cancer in Women Who Are at Risk for Lung Cancer
Condition: Lung Cancer
Interventions: Other: bronchoalveolar lavage;   Other: screening questionnaire administration;   Other: sputum cytology;   Procedure: bronchoscopic and lung imaging studies;   Procedure: bronchoscopy;   Procedure: computed tomography;   Procedure: study of high risk factors
4 Recruiting National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria
Condition: Oncology & Epidemiology & Lung Cancer
Intervention: Other: NIS observational stud
5 Unknown  Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Drug: carboplatin;   Drug: paclitaxel;   Drug: paclitaxel poliglumex
6 Unknown  GWAS Research of Lung Cancer in Tianjin
Conditions: Non-small Cell Lung Cancer;   Primary Carcinoma
Intervention:
7 Completed Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
Condition: Advanced Nonsmall Cell Lung Cancer
Intervention:
8 Terminated
Has Results
Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Postmenopausal Women
Interventions: Drug: fulvestrant (Faslodex);   Drug: anastrozole (Arimidex);   Drug: Bevacizumab (Avastin);   Drug: Best supportive care
9 Completed S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Condition: Lung Cancer
Interventions: Genetic: chromogenic in situ hybridization;   Genetic: gene expression analysis;   Genetic: mutation analysis;   Genetic: polymerase chain reaction;   Genetic: polymorphism analysis;   Other: fluorescent antibody technique;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: matrix-assisted laser desorption/ionization time of flight mass spectrometry;   Other: study of socioeconomic and demographic variables;   Procedure: study of high risk factors
10 Recruiting Exemestane in Post-Menopausal Women With NSCLC
Condition: Non-Small Cell Lung Cancer
Intervention: Drug: Exemestane
11 Unknown  Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications
Condition: Lung Cancer
Intervention:
12 Terminated A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
Condition: NSCLC
Interventions: Drug: paclitaxel;   Drug: paclitaxel poliglumex
13 Active, not recruiting Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer
Condition: Stage IV Non-small Cell Lung Cancer
Interventions: Drug: exemestane;   Drug: pemetrexed disodium;   Drug: carboplatin;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Other: questionnaire administration;   Procedure: quality-of-life assessment
14 Active, not recruiting
Has Results
Low-Dose Chest Computed Tomography Screening for Lung Cancer in Survivors of Hodgkin's Disease
Condition: Lung Cancer
Intervention: Procedure: chest computed tomography scan
15 Completed Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
Conditions: Lung Cancer;   Non Small Cell Lung Cancer (NSCLC);   Breast Cancer;   Estrogen Receptor Breast Cancer
Interventions: Drug: entinostat;   Drug: Erlotinib;   Drug: Exemestane
16 Active, not recruiting Erlotinib in Women With Previously Untreated Adenocarcinoma of the Lung
Conditions: Adenocarcinoma;   Non-small Cell Lung Cancer
Intervention: Drug: Erlotinib
17 Recruiting Real-Time Image Guided Lymphatic Mapping and Nodal Targeting in Lung Cancer
Condition: Lung Cancer
Intervention: Procedure: Near Infrared Imaging
18 Recruiting Studying Tumor Tissue Samples From Patients With Early-Stage Non-Small Cell Lung Cancer
Condition: Lung Cancer
Intervention: Other: laboratory biomarker analysis
19 Completed
Has Results
ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Conditions: Non-small Cell Lung Cancer;   Lung Cancer
Interventions: Drug: Docetaxel;   Drug: Vandetanib
20 Recruiting A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
Condition: Lung Cancer
Intervention: Other: VATS-associated best practices

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.